Answers are grounded in this paper and cite their sources.
Clinical case reveals new onset of myasthenia gravis in a patient post COVID-19 infection, highlighting potential autoimmune risks.
Development of various immune-mediated neurological complications after a viral infection is of particular interest to medical society during a pandemic of COVID-19. It was found that SARS-CoV-2 has the ability to cause hyperstimulation of the immune system, thereby initiating developing of autoimmune diseases. The article describes a clinical case of new onset of generalized myasthenia gravis with thymoma in a patient after previous COVID-19.
No takes yet. Share an insight, caveat, or question.
Алексеева et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: